(Hypertension. 1996;28:367-371.)
© 1996 American Heart Association, Inc.
Articles |
Wellcome Research Laboratories, Langley Court, Beckenham, Kent, UK, and Hadassah University Hospital, Mount Scopus, Israel (D.B.-I.).
Correspondence to Prof S. Moncada, The Cruciform Project, St Martin's House, 140 Tottenham Court Rd, London W1P 9LN, UK.
We examined the role of nitric oxide (NO) in the inherited resistance or susceptibility to hypertension in the Sabra hypertension-prone (SBH) and hypertension-resistant (SBN) rat. Basal mean arterial blood pressure was significantly greater in SBH than in SBN rats. Phenylephrine elevated blood pressure to a similar extent in both substrains, whereas the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA) had a greater pressor effect in SBN rats. The vasoconstrictor potency of phenylephrine was significantly higher in endothelium-intact aortic rings from the SBH rat, whereas the vasoconstrictor potency of L-NMMA was higher in those from the SBN substrain. Acetylcholine-induced endothelium-dependent relaxation was greater in aortic rings from SBN rats. The vasodilator potency of glyceryl trinitrate was significantly higher in aortic rings from SBH rats and was enhanced after endothelium removal. Both the activity of calcium-dependent NO synthase from aortic endothelial cells and the basal concentration of nitrite/nitrate in plasma were significantly greater in SBN than in SBH rats. In normotensive Wistar rats, basal mean arterial blood pressure, the pressor effect of L-NMMA, endothelial NO synthase activity, and plasma nitrite/nitrate concentrations were all between the values in SBH and SBN rats. These results indicate that a decrease in NO generation plays a role in the susceptibility of SBH rats to hypertension. Furthermore, the resistance to hypertension in the SBN strain may be related to increased NO generation.
Key Words: nitric oxide blood pressure rats, Sabra endothelium
This article has been cited by other articles:
![]() |
S. Iida, Y. Chu, R. M. Weiss, Y. M. Kang, F. M. Faraci, and D. D. Heistad Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H914 - H920. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chu, A. Alwahdani, S. Iida, D. D. Lund, F. M. Faraci, and D. D. Heistad Vascular Effects of the Human Extracellular Superoxide Dismutase R213G Variant Circulation, August 16, 2005; 112(7): 1047 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. CUZZOCREA, E. MAZZON, L. DUGO, R. DI PAOLA, A. P. CAPUTI, and D. SALVEMINI Superoxide: a key player in hypertension FASEB J, January 1, 2004; 18(1): 94 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. KOHLER, R. KREUTZ, A. GRUNDIG, L. ROTHERMUND, C. YAGIL, Y. YAGIL, A. R. PRIES, and J. HOYER Impaired Function of Endothelial Pressure-Activated Cation Channel in Salt-Sensitive Genetic Hypertension J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1624 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hamilton, M. J. Brosnan, M. McIntyre, D. Graham, and A. F. Dominiczak Superoxide Excess in Hypertension and Aging : A Common Cause of Endothelial Dysfunction Hypertension, February 1, 2001; 37(2): 529 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bursztyn, J. Mekler, E. Peleg, and J. Bernheim Subpressor Dose of L-NAME Unmasks Hypertensive Effect of Chronic Hyperinsulinemia Hypertension, November 1, 2000; 36(5): 872 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinozaki, Y. Nishio, T. Okamura, Y. Yoshida, H. Maegawa, H. Kojima, M. Masada, N. Toda, R. Kikkawa, and A. Kashiwagi Oral Administration of Tetrahydrobiopterin Prevents Endothelial Dysfunction and Vascular Oxidative Stress in the Aortas of Insulin-Resistant Rats Circ. Res., September 29, 2000; 87(7): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kerr, M. J. Brosnan, M. McIntyre, J. L. Reid, A. F. Dominiczak, and C. A. Hamilton Superoxide Anion Production Is Increased in a Model of Genetic Hypertension : Role of the Endothelium Hypertension, June 1, 1999; 33(6): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeda, I. Miyamori, K. Furukawa, S. Inaba, and H. Mabuchi Mechanisms of FK 506–Induced Hypertension in the Rat Hypertension, January 1, 1999; 33(1): 130 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McIntyre, C. A. Hamilton, D. D. Rees, J. L. Reid, and A. F. Dominiczak Sex Differences in the Abundance of Endothelial Nitric Oxide in a Model of Genetic Hypertension Hypertension, December 1, 1997; 30(6): 1517 - 1524. [Abstract] [Full Text] |
||||
![]() |
A. Lippoldt, V. Gross, K. Schneider, A. Hansson, S. Nadaud, W. Schneider, M. Bader, C. Yagil, Y. Yagil, and F. C. Luft Nitric Oxide Synthase and Renin-Angiotensin System Gene Expression in Salt-Sensitive and Salt-Resistant Sabra Rats Hypertension, September 1, 1997; 30(3): 409 - 415. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |